Rapid growth and geographic expansion in the biopharmaceutical market is increasing supply chain risks that need to be well understood.
In this talk, Kerry Roche-Lentine, Global Technology Management, will discuss:
- The drivers of the growth and their impact on the increasing risks in the supply chain.
- The importance of choosing a supplier partner who is prepared to manage and mitigate these risks.
Learn more: Get the report "The Changing Biopharma Risk Equation" from The Economist Intelligence Unit, sponsored by MilliporeSigma. This paper explores in detail global pharmaceutical companies' growth strategies and their plans for managing the associated risks.